MedPath

Profiling the Endocannabinoid Response to Hedonic Eating

Not Applicable
Completed
Conditions
Food Preferences
Obesity
Registration Number
NCT03113474
Lead Sponsor
Wageningen University
Brief Summary

Study into the endocannabinoid response to consuming a palatable versus a neutral food.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
25
Inclusion Criteria
  • Healthy (self-report)
  • Dutch
  • Evaluating one of the used foods as palatable
  • Evaluating one of the used foods as neutral
  • Hb value between 8.1 and 11.0 mmol/L at screening
Exclusion Criteria
  • restraint eating
  • lack of appetite
  • difficulties eating/swallowing
  • endocrine disorders
  • energy restricted diet two months prior to study
  • weight change > 5 kg in two months prior to study
  • stomach or bowel disease
  • taste or smell disorders (self-report)
  • not consuming foods used in the study
  • smoking > 1 cigarette per day
  • drinking > 21 units alcohol per week

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Endocannainoid levelsprior to, during and two hours after eating

To assess changes in endocannabinoid plasma levels prior to, during and after eating a palatable versus a neutral food

Secondary Outcome Measures
NameTimeMethod
Pancreatic polypeptide (pg/ml)prior to, during and two hours after eating

To assess changes in pancreatic polypeptide plasma levels prior to, during and after eating a palatable versus a neutral food

Ghrelin (pg/ml)prior to, during and two hours after eating

To assess changes in ghrelin plasma levels prior to, during and after eating a palatable versus a neutral food

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.